Medical and Pharmaceutical Galvanize Therapeutics finds signs Aliya PEF may activate immune response in lung cancer The findings could help researchers understand whether Aliya treatments can complement existing cancer immunotherapies Joseph Morton19 hours ago
Medical and Pharmaceutical Korean medtech operator Rayence launches portable ‘Anywhere’ X-ray Rayence's latest and greatest mobile devices feature a proprietary new de-noising feature Rowan Dunne1 day ago
Medical and Pharmaceutical Artificial heart maker Picard soars from 39% revenue spike, narrowed net loss SynCardia's Total Artificial Heart serves as a temporary solution while patients wait for donors Rowan Dunne3 days ago
Medical and Pharmaceutical Young Muay Thai fighter’s lung cancer death raises screening eligibility concerns Many heavy smokers live into their senior years while others are taken far too young Rowan Dunne4 days ago
Medical and Pharmaceutical Craif raises US$33M to get its urine cancer test into American clinics Milestone follows the firm opening a California lab in April Rowan Dunne7 days ago
Medical and Pharmaceutical Scribe Therapeutics develops one-time cholesterol treatment without permanent gene editing Scribe instead wants one treatment to keep PCSK9 switched down for an extended period Joseph Morton7 days ago
Medical and Pharmaceutical Moderna ascends more than 175% from cancer vaccine breakthrough It marks the first successful Phase 3 trial for an mRNA-based cancer therapy Rowan DunneAugust 20, 2026
Medical and Pharmaceutical Research shines light on efficacy of ‘Inflammacheck’ lung cancer breath test Small study yielded high accuracy, though larger-scale validation is still needed Rowan DunneAugust 19, 2026
Medical and Pharmaceutical New USD$60 blood test detects lung cancer using DNA chemical fingerprints The team extracts cell-free DNA from a blood sample and chemically processes selected sections Joseph MortonAugust 18, 2026
Medical and Pharmaceutical Surgical robotics leader Intuitive sets up shop in Penang, Malaysia Medtech firm will invest nearly half a billion over 5 years Rowan DunneAugust 16, 2026